Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more
Morning Sickness Drugs Repurposing
News 17/09/2024

Morning Sickness: The Role of Drug Repurposing and Intellectual Property Considerations

Charlotte Cell & Gene Meeting On The Mesa
Events, News 17/09/2024

Secerna to attend Cell & Gene Meeting on the Mesa in Phoenix, USA

John, Jon NEPIC
Events, News, Team news 17/09/2024

Secerna to attend NEPIC Meet the Members Expo 2024

Recruitment Article 2024
News, Careers 10/09/2024

Join Secerna: Graduate Trainee Patent Attorney – Physics/Electronics

B012362
Team news, Careers 09/09/2024

Join Secerna: Graduate Trainee Patent Attorney – Life Sciences

EPO 2021
European, Industry news, News 04/09/2024

Navigating the Digital EPO: A Guide to Online Patent Filing, Management, and Collaboration

IPO Image Istock (1)
Industry news, News 02/09/2024

UK IPO Introduces Statements of Grant for International Designs

B012424
Events, News 26/08/2024

Secerna to attend Wakefield Tech & Net Zero Expo 2024

Water Tech Patents A Growing Wave Of Innovation
European, Industry news, News 20/08/2024

Water Tech Patents: A Growing Wave of Innovation

4 5 6 7 8 9 10 11 12 13 14